Tehran Times

POGC rises gas extraction from South Pars phase 11

Referring to the fact that daily gas extraction from phase 11 of South Pars was over 12 million cubic meters in late August 2025, Keyvan Tarighati stated: “Development of this phase has been pursued ...
ascopubs.org

A phase 1 first-in-human clinical trial of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, in advanced solid tumors.

Phase 1 study of LB1410, a bivalent TIM-3/PD-1 bispecific antibody, in patients with advanced solid tumors or lymphoma. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...
ascopubs.org

First in human phase I study of TQB2103, a Claudin18.2 (CLDN18.2) targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors.

A phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HLX43 (anti-PD-L1 ADC) in patients with advanced/metastatic solid tumors. Association of genomic ...
FierceBiotech

Cancer imaging company buys Lisata for phase 2-stage solid tumor drug

Cancer imaging company Kuva Labs is expanding its scope via the acquisition of solid tumor biotech Lisata Therapeutics. The big prize for Kuva is certepetide, Lisata’s cyclic peptide drug that the ...